Kerna
701 S. Carson Street, Suite 200, Carson City, Nevada, 89701, United States
Overview
Kerna Ventures is an early-stage venture capital firm that invests in advanced therapeutic platform technologies, focusing on genome engineering, cell reprogramming, and computational biology. Kerna Ventures typically invests in seed through Series A funding rounds, with ticket sizes ranging from $0.5 million to $5 million.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 0
Sector focus
- Financial Services
- Impact Investing
- Therapeutics
- Venture Capital
Investment portfolio
- Aerska
Participated · Seed · Oct 2025
Aerska is developing delivery technologies intended to enable systemic delivery of RNA medicines to the brain to treat serious neurological diseases. The company is focused on improving selectivity of RNAi payload delivery and on approaches that could target multiple disease pathways simultaneously. Aerska announced an additional $10M investment from GHIC as part of its Series A, indicating ongoing Series A financing activity. The company positions the GHIC investment as a partnership to advance its platform toward clinical or translational goals. No public operating metrics or founding date were disclosed in the announcement.
Team
No current team members are available.